Preclinical scientific tests suggest that retatrutide could impact obesity-connected cancer development. In a examine led by Marathe et al., retatrutide-induced weightloss reduced tumor engraftment, delayed tumor onset, and drastically attenuated tumor advancement in pancreatic and lung cancer mo